Last month, the Medicines & Healthcare products Regulatory Agency (“MHRA“) published guidance on “Software and Artificial Intelligence (AI) as a Medical Device”.
It didn’t necessarily provide for any new regulatory approach to AI in the therapeutic space, but it brought together some important material during this period of increasing interest in AI to effectively remind software providers of their compliance obligations in the life sciences and healthcare space.
READ THE FULL ARTICLE ON BIOTALK HERE
For further information, please contact:
Sophie Vo, Bird & Bird
sophie.vo@twobirds.com
